Filing Details
- Accession Number:
- 0001209191-17-059139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-03 16:01:24
- Reporting Period:
- 2017-11-01
- Accepted Time:
- 2017-11-03 16:01:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202335 | W David Gryska | 1801 Augustine Cut-Off Wilmington DE 19803 | Executive Vice President, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-11-01 | 3,913 | $107.96 | 17,907 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-11-02 | 3,915 | $105.63 | 13,992 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares withheld to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $104.51 - $107.74.
- Includes an aggregate of 13,316 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Billionaire Hedge Funds
